A1 Refereed original research article in a scientific journal

Novel troponin fragmentation assay to discriminate between Takotsubo syndrome and acute myocardial infarction




AuthorsAiraksinen, Juhani K. E.; Tuominen, Tuulia; Paana, Tuomas; Hellman, Tapio; Vasankari, Tuija; Salonen, Selma; Junes, Helea; Linko-Parvinen, Anna; Pallari, Hanna-Mari; Strandberg, Marjatta; Teppo, Konsta; Jaakkola, Samuli; Wittfooth, Saara

PublisherOXFORD UNIV PRESS

Publishing placeOXFORD

Publication year2024

JournalEuropean Heart Journal: Acute Cardiovascular Care

Journal name in sourceEUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE

Journal acronymEUR HEART J-ACUTE CA

Volume13

Issue11

First page 782

Last page788

Number of pages7

ISSN2048-8726

eISSN2048-8734

DOIhttps://doi.org/10.1093/ehjacc/zuae115

Web address https://doi.org/10.1093/ehjacc/zuae115

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/470919888


Abstract

Aims

Cardiac troponin levels are elevated in Takotsubo syndrome (TTS) with significant overlap to acute myocardial infarction (MI). Long and intact cardiac troponin T (cTnT) forms are typical for MI. This study sought to assess whether the fragmentation composition of cTnT release in TTS differs from MI.

Methods and results

The concentration of long molecular forms of cTnT (long cTnT) was measured with a novel upconversion luminescence immunoassay and total cTnT with a commercial high-sensitivity cTnT assay in 24 TTS patients and in 84 Type 1 MI patients. The ratio of long to total cTnT (troponin ratio) was determined as a measure of cTnT fragmentation. Troponin ratio was lower in TTS patients [0.13 (0.10-0.20) vs. 0.62 (0.29-0.96), P < 0.001]. In the receiver operating characteristic curve analyses, troponin ratio showed a better predictive power than total cTnT in discriminating TTS and MI patients {area under the curve [AUC] 0.869 [95% confidence interval (CI) 0.789-0.948] vs. 0.766 [95% CI 0.677-0.855], P = 0.047}. When restricting the analysis to patients with total cTnT below 1200 ng/L (maximal value in TTS patients), the respective AUC values for total cTnT and troponin ratio were 0.599 (95% CI 0.465-0.732) and 0.816 (95% CI 0.712-0.921) (P = 0.003). At a cut-off point of 0.12, troponin ratio correctly identified 95% of MI patients and 50% of TTS patients.

Conclusion

In contrast to Type 1 MI, only a small fraction of circulating cTnT in TTS exists in intact or long molecular forms. This clear difference in troponin composition could be of diagnostic value when evaluating patients with cTnT elevations and suspicion of TTS.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
This work was supported by the Finnish Foundation for Cardiovascular Research, Helsinki, Finland; Clinical Research Fund (EVO) of Turku University Hospital, Turku, Finland; Business Finland, Helsinki, Finland; the Finnish Society of Clinical Chemistry, Helsinki, Finland; the Turku University Foundation, Turku, Finland; and the Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation, Turku, Finland. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.


Last updated on 2025-27-01 at 19:35